Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.7K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.7K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

511
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
511
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Flatter Tacrolimus Pharmacokinetic Profiles in Pediatric Kidney Transplant Recipients Receiving Liquid Formulations: A Quality Improvement Study.

Pediatric transplantation·2026
Same author

Serological and molecular study of Hepatitis E virus in pediatric patients in Mexico.

Annals of hepatology·2020
Same author

[Long term follow up of a patient with type I vitamin D-dependent rickets].

Boletin medico del Hospital Infantil de Mexico·2018
Same author

[Nutcracker syndrome: Cause of non-glomerular hematuria and massive proteinuria].

Boletin medico del Hospital Infantil de Mexico·2018
Same author

[Congenital hepatic fibrosis: Complications and management].

Boletin medico del Hospital Infantil de Mexico·2018
Same author

Randomized Controlled Trial of Mineralocorticoid Receptor Blockade in Children with Chronic Kidney Allograft Nephropathy.

Clinical journal of the American Society of Nephrology : CJASN·2017

Related Experiment Video

Updated: Feb 14, 2026

Isolation and Culture of Cells from the Nephrogenic Zone of the Embryonic Mouse Kidney
08:06

Isolation and Culture of Cells from the Nephrogenic Zone of the Embryonic Mouse Kidney

Published on: April 22, 2011

18.6K

[Nephrogenic diabetes insipidus].

Luis Velásquez-Jones1, Mara Medeiros-Domingo2

  • 1Departamento de Nefrología Dr. Gustavo Gordillo Paniagua, Hospital Infantil de México Federico Gómez, México, D.F., México.

Boletin Medico Del Hospital Infantil De Mexico
|February 9, 2018
PubMed
Summary
This summary is machine-generated.

Nephrogenic diabetes insipidus (NDI) occurs when kidneys resist anti-diuretic hormone (ADH). This review covers NDI causes, symptoms, diagnosis, and treatments, exploring new therapeutic strategies.

Keywords:
Aquaporin-2 water channelArginine-vasopressin type-2 receptorCanal acuoso acuaporina-2Diabetes insípida nefrogénicaNephrogenic diabetes insipidusPoliuriaPolyuriaReceptor tipo 2 de la arginina vasopresina

More Related Videos

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
10:43

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice

Published on: October 31, 2007

28.9K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.2K

Related Experiment Videos

Last Updated: Feb 14, 2026

Isolation and Culture of Cells from the Nephrogenic Zone of the Embryonic Mouse Kidney
08:06

Isolation and Culture of Cells from the Nephrogenic Zone of the Embryonic Mouse Kidney

Published on: April 22, 2011

18.6K
Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
10:43

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice

Published on: October 31, 2007

28.9K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.2K

Area of Science:

  • Nephrology
  • Endocrinology
  • Molecular Biology

Context:

  • Arginine-vasopressin (AVP) regulates water reabsorption in kidney collecting ducts via the AVPR2 receptor and aquaporin-2 channels.
  • Nephrogenic diabetes insipidus (NDI) results from renal resistance to AVP's effects.
  • NDI can be congenital (genetic mutations in AVPR2 or AQP2) or acquired (electrolyte imbalances, diseases, drugs like lithium).

Purpose:

  • To review the causes, clinical manifestations, diagnosis, and treatment of nephrogenic diabetes insipidus.
  • To provide an overview of current understanding and emerging therapeutic strategies for NDI.

Summary:

  • AVP binding to AVPR2 triggers aquaporin-2 translocation, increasing apical membrane water permeability and facilitating osmotic water reabsorption.
  • NDI is characterized by the inability to concentrate urine due to impaired renal response to AVP.
  • Acquired NDI has diverse etiologies including hypercalcemia, hypokalemia, renal diseases, and lithium toxicity.

Impact:

  • Enhances understanding of NDI pathophysiology, aiding in accurate diagnosis and management.
  • Highlights the importance of identifying underlying causes for effective treatment of NDI.
  • Informs the development of novel therapeutic approaches for patients with NDI based on mechanistic insights.